海外参会速递丨共赴巴塞罗那！成都先导邀您相聚Drug Discovery Chemistry Europe 2025 发布时间：2025-11-05

演讲人：

Ben Davis, Research Fellow & Director of Business Development, Vernalis

演讲题目：

Integrating FBDD with DEL and other hit ID strategies

演讲时间：

2025年11月11日15:20-15:35（当地时间）

地点：C2A-Lead Generation Strategies论坛

Drug Discovery Chemistry Europe（DDCE），由Cambridge Healthtech Institute主办，是欧洲乃至全球药物化学与早期药物研发领域极具影响力的国际会议。

DDCE 2025将于11月11-13日在西班牙巴塞罗那举行。作为汇聚全球制药企业、生物科技公司和学术机构的核心展示平台，本次会议将为行业带来最前沿的科技成果，各个分会场覆盖了先导化合物生成策略、下一代降解剂与分子胶、蛋白质互作、人工智能驱动的药物优化、FBDD、DEL筛选等主题，为药物发现、药物化学及计算化学领域的产业及科研人员提供深度交流空间。

成都先导商务及化学科学副总裁Alex Shaginian博士、商务开发副总监余诗淼，成都先导英国子公司Vernalis 研究员兼商务总监Ben Davis博士、商业总监Kerry Waters将赴西班牙参会。Ben Davis博士还会带来精彩演讲。期待与行业同仁相聚交流，碰撞思想！

会议期间，成都先导将在#1展位恭候您的光临，我们巴塞罗那见！

演讲嘉宾

Ben Davis

Dr. Ben Davis is a Research Fellow and Director of Business Development at Vernalis Research, a biotech company based in Cambridge UK which has been at the forefront of fragment-based approaches since 1998. An NMR spectroscopist and biophysicist by training, his current research focus is the development of biophysics and FBLD methods for challenging therapeutic targets and systems. Dr Davis studied for his PhD in protein folding and molecular interactions with Professor Alan Fersht at Cambridge University, and then studied the interactions of small molecules with proteins and RNA. He has over 20 years’ experience in the drug discovery industry. He has contributed to seven books over the last decade and is an author on more than forty scientific publications. He is a frequent speaker at scientific conferences and has been running FBLD training workshops since 2007.